ClinicalTrials.gg
Not yet recruitingNCT07311031Updated Jan 5, 2026

Effect of Blood Flow Restriction Rraining on Rehabilitation After Anterior Cruciate Ligament Reconstruction

An interventional study of Blood flow restriction training and Standard ACL rehabilitation in Anterior Cruciate Ligament Reconstruction Rehabilitation and Blood Flow Restriction (BFR) Training Effects, sponsored by Hospital MAZ. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Hospital MAZ · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Knee Injuries with a site in Spain — 4 open to participants now, 4 under way, none of them phase 3. Knee Injuries · Spain.

Planned enrollment
5th of 15
60 · median 40
Started
2025
the only one that year
No phase
14 of 18
3 open now
Registered
17th of 18
by date
Lead sponsor
1 of 18
Hospital MAZ

Among the 18 studies in Knee Injuries with a site in Spain, this one is the 5th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is one of 14 with no phase, and was the 17th registered.

Knee Injuries

267 studies on the registry are indexed under Knee Injuries; 59 are open to participants now.

Browse Knee Injuries studies →

Open to participants now

4 of the 18 studies in Knee Injuries with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 42 Knee Injuries studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger; 12 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Knee Injuries with a site in Spain, or all of them as a file.
02

Study summary

Importance: Following anterior cruciate ligament reconstruction (ACLR), patients often experience quadriceps muscle weakness and atrophy, frequently leading to long-term complications. A promising rehabilitation program based on blood flow restriction training (BFRT) seems to be particularly valuable for patients who may be unable to train with heavy loads due recent surgery. Previous studies have demonstrated that BFRT promotes strength gains and muscle mass increases, with adaptations comparable to traditional high-intensity training, despite using low-load resistance exercises.

Objective: to evaluate the effect of blood flow restriction training on quadriceps strength and knee biomechanics in a 4-month rehabilitation program of patients who have had an ACL reconstruction.

Design: The study will be a two-arm superiority randomized controlled clinical trial.

Setting: The trial will be conducted at a work-related injuries specialised hospital, MAZ Hospital, Zaragoza, Spain.

Participants: Participants will be active workers who have suffered an acute ACL tear and they have undergone ACL reconstruction (n=60).

Intervention: Patients will recieve a 14-16-week supervised accelerated early rehabilitation protocol; one group will complete it applying blood flow restriction training and the other will not.

Main Outcome and Measure: The primary outcomes will be peak quadriceps strength and rate of torque development measured both isometrically and isokinetcally with a Isokinetic Dynamometer CON-TREX MG.

Limitations: Potential limitations include patients and physiotherapists are not blinded.

Conclusions: The focus of the research will examine the impact of blood flow restriction rehabilitation on patients who have undergone ACLR.

Relevance: The study has potential to restore quadriceps strength to a greater extent than standard rehabilitation protocol. Moreover, patients will spend less time in the rehabilitation process to return to work compared to standard care.

03

Conditions studied

  • Anterior Cruciate Ligament Reconstruction Rehabilitation
  • Blood Flow Restriction (BFR) Training Effects

Browse trials for

Keywords

  • KAATSU
  • Knee injury
  • ACL rehabilitation
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female (18-65 years of age); must be skeletally mature with closed physes
  • Worker active
  • Diagnosis of acute (\<8 weeks), unilateral ACL tear with planned surgery confirmed via clinical examination and MRI
  • No previous ACL injury or reconstruction on the involved limb
  • Planned graft: autologous ipsilateral hamstring graft for ACL reconstruction
  • Planned fixation: suspensory cortical femoral device and tibial interference screw

Exclusion criteria

Exclusion Criteria:

  • Completed knee dislocation or multiligament injury (PCL, MCL, LCL)
  • ACL Graft diameter \< 8mm
  • Meniscal suture or meniscal root reattachment
  • Post-surgical immobilization
  • Any current or previous conditions or surgeries that might affect gait
  • Pregnant
  • Spinal fusion
  • Any implanted medical device or other for MRI
  • History of deep vein thrombosis and/or varicose veins or familiy history of deep vein thrombosis
  • Taking anti-coagulant drugs for any blood, cardiac or congenital disease that may cause coagulation disorders
  • Taking bone and muscle metabolism-modulation drugs or muscle supplements (e.g., creatine, amino acids, whey protein,…)
  • Recent inflammation, bleeding disorders, active bleeding, or infection within the lower limbs
  • Diabetic or have uncontrolled hypertension
  • Diminished capacity to provide
  • Unfeasible to attend regular physical therapy and study visits
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    BFRT rehabilitation group

    Receive standard ACL physical therapy plus blood flow restriction training

    Other: Blood flow restriction training · Other: Standard ACL rehabilitation

  • Active comparator
    Standard rehabilitation group

    Receive standard ACL physical therapy

    Other: Standard ACL rehabilitation

Interventions

  • OtherBlood flow restriction training

    BFRT consists of a pressurized cuff that is applied to the proximal thigh in order to partially occlude blood flow while the patient exercises. It is believed that the accumulated effects of fatigue, mechanical tension, metabolic stress and reactive hyperaemia contribute to promoting adaptation of the quadriceps with minimal strain. Therefore, patients can train at reduced loads and may receive the same training benefits as if they were training with high loads.

  • OtherStandard ACL rehabilitation

    A 14-16-week supervised accelerated early rehabilitation protocol was selected based on previous evidence.8 It is characterised by early unrestricted motion and weight-bearing, without the use of an immobilising brace and commencing early strength training.

06

What researchers measure

Primary outcomes

  1. Quadriceps strength

    Peak quadriceps strength

    Time frame: From enrollment to the end of treatment at 14 weeks

  2. Quadriceps strength

    Rate of torque

    Time frame: From enrollment to the end of treatment at 14 weeks

07

Study locations

1 site
  • MAZ Hospital
    Zaragoza, Zaragoza 50009, Spain
08

References and documents

Publications

  • Erickson LN, Lucas KCH, Davis KA, Jacobs CA, Thompson KL, Hardy PA, Andersen AH, Fry CS, Noehren BW. Effect of Blood Flow Restriction Training on Quadriceps Muscle Strength, Morphology, Physiology, and Knee Biomechanics Before and After Anterior Cruciate Ligament Reconstruction: Protocol for a Randomized Clinical Trial. Phys Ther. 2019 Aug 1;99(8):1010-1019. doi: 10.1093/ptj/pzz062. PubMed 30951598 ↗
  • Gopinatth V, Garcia JR, Reid IK, Knapik DM, Verma NN, Chahla J. Blood Flow Restriction Enhances Recovery After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2025 Apr;41(4):1048-1060. doi: 10.1016/j.arthro.2024.05.032. Epub 2024 Jun 16. PubMed 38889851 ↗
  • Erickson LN, Owen MK, Casadonte KR, Janatova T, Lucas K, Spencer K, Brightwell BD, Graham MC, White MS, Thomas NT, Latham CM, Jacobs CA, Conley CE, Thompson KL, Johnson DL, Hardy PA, Fry CS, Noehren B. The Efficacy of Blood Flow Restriction Training to Improve Quadriceps Muscle Function after Anterior Cruciate Ligament Reconstruction. Med Sci Sports Exerc. 2025 Feb 1;57(2):227-237. doi: 10.1249/MSS.0000000000003573. Epub 2024 Oct 1. PubMed 39350350 ↗
  • Mather RC 3rd, Koenig L, Kocher MS, Dall TM, Gallo P, Scott DJ, Bach BR Jr, Spindler KP; MOON Knee Group. Societal and economic impact of anterior cruciate ligament tears. J Bone Joint Surg Am. 2013 Oct 2;95(19):1751-9. doi: 10.2106/JBJS.L.01705. PubMed 24088967 ↗
  • Matar HE, Platt SR, Bloch BV, James PJ, Cameron HU. A Systematic Review of Randomized Controlled Trials in Anterior Cruciate Ligament Reconstruction: Standard Techniques Are Comparable (299 Trials With 25,816 Patients). Arthrosc Sports Med Rehabil. 2021 May 14;3(4):e1211-e1226. doi: 10.1016/j.asmr.2021.03.017. eCollection 2021 Aug. PubMed 34430902 ↗

Individual participant data

Plan to share: Yes — Trained researchers will collect data from MAZ Hospital. All information collected during this trial will always be protected and securely stored by the lead researcher. The lead researcher will assign a secure locker in his office to store all investigation documents. Additionally, all electronic material will be safely stored and backed up on the researcher's computer equipment with a secure password.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Sep 2026, 8 months later.

Of 94 non-industry interventional studies with no phase under Knee Injuries, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 51. This study's planned 8 months is below that.

Counting every sponsor, half of 99 studies reached it within 20 months; a quarter within 8 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2025
First posted
Dec 30, 2025
StartEst.
Dec 20, 2025
Primary completionEst.
Sep 1, 2026
CompletionEst.
Sep 1, 2027
Last update
Jan 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07311031
Lead sponsor
Hospital MAZ
Responsible party
Raul Zapata Rodrigo (Orthopaedic Surgeon, Hospital MAZ) — Principal investigator
First posted
Dec 30, 2025
Start date
Dec 20, 2025 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Jan 5, 2026

Study contacts

Raul Zapata-Rodrigo, Orthopaedic Surgeon
Contact
raulzapatarodrigo@gmail.com
+34620727950
Jose Antonio Casajus Mallen, University professor
study chair · Universidad de Zaragoza

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion